Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bone Biologics Corp

BBLG
Current price
1.82 USD -0.34 USD (-15.74%)
Last closed 1.73 USD
ISIN US0980703039
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 1 441 144 USD
Yield for 12 month -70.07 %
1Y
3Y
5Y
10Y
15Y
BBLG
21.11.2021 - 28.11.2021

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. Address: 2 Burlington Woods Drive, Burlington, MA, United States, 01803

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

16.75 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures BBLG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -824 964 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -57.25 %
PEG Ratio
Return On Equity TTM -119.03 %
Wall Street Target Price 16.75 USD
Revenue TTM
Book Value 2.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -17.24 USD
Diluted Eps TTM -17.24 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BBLG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BBLG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:8
Payout Ratio
Last Split Date 20.12.2023
Dividend Date 24.07.2018

Stock Valuation BBLG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1345
Price Book MRQ 0.4954

Financials BBLG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BBLG

For 52 weeks

0.8 USD 7.98 USD
50 Day MA 1.49 USD
Shares Short Prior Month 18 207
200 Day MA 2.31 USD
Short Ratio
Shares Short 12 501
Short Percent 0.71 %